Tower Research Capital LLC (Trc) Infinity Pharmaceuticals, Inc. Transaction History

Tower Research Capital LLC (Trc)

$3.68 Billion
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$0.14 - $0.24 $97 - $166	-694 Reduced 2.63%	25,649 $5,000
Q1 2023 May 09, 2023	BUY	$0.16 - $0.74 $180 - $833	1,127 Added 4.47%	26,343 $4,000
Q4 2022 Feb 10, 2023	BUY	$0.46 - $1.21 $1,444 - $3,799	3,140 Added 14.22%	25,216 $14,000
Q3 2022 Nov 10, 2022	BUY	$0.59 - $1.7 $2,855 - $8,226	4,839 Added 28.07%	22,076 $26,000
Q2 2022 Aug 15, 2022	BUY	$0.49 - $1.2 $3,852 - $9,434	7,862 Added 83.86%	17,237 $11,000
Q1 2022 May 12, 2022	SELL	$0.85 - $2.4 $24,276 - $68,546	-28,561 Reduced 75.29%	9,375 $11,000
Q4 2021 Feb 14, 2022	BUY	$1.86 - $3.36 $61,435 - $110,980	33,030 Added 673.26%	37,936 $85,000
Q3 2021 Nov 15, 2021	SELL	$1.52 - $3.82 $449 - $1,130	-296 Reduced 5.69%	4,906 $17,000
Q2 2021 Aug 16, 2021	SELL	$2.66 - $3.47 $68,941 - $89,935	-25,918 Reduced 83.28%	5,202 $16,000
Q1 2021 May 17, 2021	BUY	$1.98 - $5.36 $31,087 - $84,157	15,701 Added 101.83%	31,120 $100,000
Q4 2020 Feb 16, 2021	BUY	$1.05 - $2.77 $16,189 - $42,710	15,419 New	15,419 $33,000
Q3 2020 Nov 16, 2020	SELL	$0.82 - $1.34 $13 - $22	-17 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$0.77 - $1.13 $13 - $19	17 New	17 $0
Q1 2020 May 15, 2020	SELL	$0.69 - $1.52 $8,162 - $17,980	-11,829 Closed	0 $0
Q4 2019 Feb 07, 2020	BUY	$0.88 - $1.29 $8,239 - $12,078	9,363 Added 379.68%	11,829 $11,000
Q3 2019 Nov 05, 2019	BUY	$1.03 - $1.75 $2,539 - $4,315	2,466 New	2,466 $3,000
Q2 2019 Aug 13, 2019	SELL	$1.43 - $1.87 $3,865 - $5,054	-2,703 Closed	0 $0
Q1 2019 May 14, 2019	SELL	$1.18 - $1.91 $3,239 - $5,242	-2,745 Reduced 50.39%	2,703 $5,000
Q4 2018 Feb 14, 2019	BUY	$1.01 - $2.78 $5,502 - $15,145	5,448 New	5,448 $6,000
Q2 2018 Aug 15, 2018	SELL	$1.72 - $2.26 $665 - $874	-387 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$1.8 - $2.74 $2,298 - $3,498	-1,277 Reduced 76.74%	387 $1,000
Q4 2017 Feb 09, 2018	BUY	$1.22 - $3.73 $2,030 - $6,206	1,664 New	1,664 $3,000
Q3 2017 Nov 14, 2017	BUY	$0.94 - $1.35 $0 - $0	0	0 $0

Others Institutions Holding INFI

# of Institutions

Shares Held

1.26M

Call Options Held

Put Options Held

View Full List

About INFINITY PHARMACEUTICALS, INC.

Ticker INFI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 89,277,904
Description
Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Its product candidate is IPI-549, an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-kinase-gamma, which is in Phase 2 clinical trials for the treatment of met...

More about INFI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account